The increased risk of mortality in patients with gout is increasingly recognized, and multiple guidelines call for better management of this disease and its comorbidities. A new study, however, has found that excess mortality in patients with gout has remained unchanged since 1999.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study
Rheumatology and Therapy Open Access 07 December 2020
-
Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options
BMC Medicine Open Access 03 July 2017
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Doherty, M. et al. Gout: why is this curable disease so seldom cured? Ann. Rheum. Dis. 71, 1765–1770 (2012).
Clarson, L. E. et al. Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis. Eur. J. Prev. Cardiol. 22, 335–343 (2015).
Fisher, M. C., Rai, S. K., Lu, N., Zhang, Y. & Choi, H. K. The unclosing premature mortality gap in gout: a general population-based study. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2016-210588 (2017).
Zhang, Y. et al. Improved survival in rheumatoid arthritis: a general population-based cohort study. Ann. Rheum. Dis. 76, 408–413 (2017).
O'Keeffe, A. G., Nazareth, I. & Petersen, I. Time trends in the prescription of statins for the primary prevention of cardiovascular disease in the United Kingdom: a cohort study using The Health Improvement Network primary care data. Clin. Epidemiol. 8, 123–132 (2016).
Kuo, C. F., Grainge, M. J., Mallen, C., Zhang, W. & Doherty, M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann. Rheum. Dis. 74, 661–667 (2015).
Kuo, C. F. et al. Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology (Oxford) 52, 127–134 (2013).
Kuo, C. F., Grainge, M. J., Mallen, C., Zhang, W. & Doherty, M. Comorbidities in patients with gout prior to and following diagnosis: case-control study. Ann. Rheum. Dis. 75, 210–217 (2016).
Dalbeth, N. & Stamp, L. Hyperuricaemia and gout: time for a new staging system? Ann. Rheum. Dis. 73, 1598–1600 (2014).
Richette, P. et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann. Rheum. Dis. 76, 29–42 (2017).
Acknowledgements
The authors thank I.-J. Chou for helpful discussions. The research of C.-F.K is supported by grants from Chang Gung Memorial Hospital (CORP3E0142, CMRPG3F2141) and Ministry of Science and Technology in Taiwan (NMRPG3F6281).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Kuo, CF., Luo, SF. Risk of premature death in gout unchanged for years. Nat Rev Rheumatol 13, 200–201 (2017). https://doi.org/10.1038/nrrheum.2017.27
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2017.27
This article is cited by
-
Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study
Rheumatology and Therapy (2021)
-
Colchicin zur Behandlung der Gicht
rheuma plus (2018)
-
Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options
BMC Medicine (2017)